Metastatic porocarcinoma: A case demonstrating objective response to pembrolizumab
oleh: Camélia Benhayoun, Anne Bénédicte Duval Modeste, MD, Clémence Tamarit, MD, Pascal Joly, PhD, Raphaël Janela-Lapert, MD
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2024-08-01 |
Deskripsi
Subjek
anti-PD1; immunotherapy; metastatic porocarcinoma; partial remission; pembrolizumab